Schrüfer Philipp, Brockow Knut, Stoevesandt Johanna, Trautmann Axel
Department of Dermatology and Allergy, Allergy Center Mainfranken, University Hospital Würzburg, 97080, Würzburg, Germany.
Department of Dermatology and Allergy, Technical University of Munich, 80802, Munich, Germany.
Allergy Asthma Clin Immunol. 2020 Nov 17;16(1):102. doi: 10.1186/s13223-020-00488-0.
Penicillins and other β-lactam antibiotics are the most common elicitors of allergic drug reaction. However, data on the pattern of clinical reaction types elicited by specific β-lactams are scarce and inconsistent. We aimed to determine patterns of β-latam allergy, i.e. the association of a clinical reaction type with a specific β-lactam antibiotic.
We retrospectively evaluated data from 800 consecutive patients with suspected β-lactam hypersensitivity over a period of 11 years in a single German Allergy Center.
β-lactam hypersensitivity was definitely excluded in 595 patients, immediate-type (presumably IgE-mediated) hypersensitivity was diagnosed in 70 and delayed-type hypersensitivity in 135 cases. Most (59 out of 70, 84.3%) immediate-type anaphylactic reactions were induced by a limited number of cephalosporins. Delayed reactions were regularly caused by an aminopenicillin (127 out of 135, 94.1%) and usually manifested as a measles-like exanthem (117 out of 135, 86.7%). Intradermal testing proved to be the most useful method for diagnosing β-lactam allergy, but prick testing was already positive in 24 out of 70 patients with immediate-type hypersensitivity (34.3%). Patch testing in addition to intradermal testing did not provide additional information for the diagnosis of delayed-type hypersensitivity. Almost all β-lactam allergic patients tolerated at least one, usually several alternative substances out of the β-lactam group.
We identified two patterns of β-lactam hypersensitivity: aminopenicillin-induced exanthem and anaphylaxis triggered by certain cephalosporins. Intradermal skin testing was the most useful method to detect both IgE-mediated and delayed-type β-lactam hypersensitivity.
青霉素及其他β-内酰胺类抗生素是药物过敏反应最常见的引发因素。然而,关于特定β-内酰胺类药物引发的临床反应类型模式的数据却很稀少且不一致。我们旨在确定β-内酰胺过敏模式,即临床反应类型与特定β-内酰胺类抗生素之间的关联。
我们回顾性评估了德国一家过敏中心11年间连续800例疑似β-内酰胺过敏患者的数据。
595例患者被明确排除β-内酰胺过敏,70例诊断为速发型(可能由IgE介导)过敏,135例为迟发型过敏。大多数(70例中的59例,84.3%)速发型过敏反应由少数几种头孢菌素引起。迟发型反应通常由氨基青霉素引起(135例中的127例,94.1%),且通常表现为麻疹样皮疹(135例中的117例,86.7%)。皮内试验被证明是诊断β-内酰胺过敏最有用的方法,但在70例速发型过敏患者中,有24例(34.3%)的点刺试验已呈阳性。除皮内试验外,斑贴试验并未为迟发型过敏的诊断提供更多信息。几乎所有β-内酰胺过敏患者都能耐受β-内酰胺类中的至少一种,通常是几种替代药物。
我们确定了两种β-内酰胺过敏模式:氨基青霉素引起的皮疹和某些头孢菌素引发的过敏反应。皮内皮肤试验是检测IgE介导的和迟发型β-内酰胺过敏最有用的方法。